Screening passengers as they arrive at UK airports is unlikely to prevent the importation of either SARS or influenza, finds a study published by the British Medical Journal.
In the event of a new SARS or influenza epidemic, air travel would represent the principal route of international spread. Although airport entry screening has been advocated, its benefit is currently unknown. Using the incubation periods for influenza and SARS, researchers at the Health Protection Agency estimated the proportion of passengers with latent infection who would develop symptoms during any flight to the United Kingdom.
For SARS, they found that the incubation period was too long to allow more than a small proportion of infected individuals to develop symptoms during a flight to the UK (0 percent to 3 percent for European flights and a maximum of 21 percent for the longest flights from East Asia).
Although influenza has a much shorter incubation period than SARS, the average predicted proportion of people infected with influenza and progressing during any flight was still less than 10 percent.
Because the proportion of individuals detected is highest from cities with the longest flight duration, screening passengers from the Far East and Australasia derives the most benefit. But, even then, the sensitivity for cities in these areas would still be low, explain the authors.
Early screening is unlikely to be effective in preventing the importation of either SARS or influenza, they conclude.
Although adopting a policy of quarantining all exposed passengers on the detection of a single case could substantially increase the benefit of entry screening, this still leaves the problem that the sensitivity of entry screening is low.
Source: British Medical Journal
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.
From Shortages to Security: How Reusable Health Care Textiles Can Transform Infection Prevention
March 7th 2025Reusable health care textiles enhance infection prevention, reduce waste, and strengthen supply chains. Hygienically clean textiles offer a sustainable, cost-effective alternative to disposable PPE, ensuring patient safety and environmental responsibility.